PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperphosphatemia |
| Phenotype | C0022661|chronic renal failure |
| Sentences | 5 |
| PubMedID- 20486851 | Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials. |
| PubMedID- 24235818 | Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence. |
| PubMedID- 25817287 | The current therapy for hyperphosphatemia in patients with chronic renal failure consists of dietary pi restriction combined with administration of pi binders, but each therapy has practical problems. |
| PubMedID- 25866250 | hyperphosphatemia is common in patients with chronic renal failure. |
| PubMedID- 24975675 | Ferric citrate hydrate (jtt-751) is being developed as a treatment for hyperphosphatemia with chronic renal failure and has shown a serum phosphorus-lowering effect in ckd patients. |
Page: 1